Clinical Tiral of Suhuang Zhike Capsule in Treating Cough after Thoracoscopic Pneumonectomy for Early Non-small Cell Lung Cancer

Peking University people's Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients who underwent thoracoscopic sublobe, lobe, compound lobe or pneumonectomy, with or without mediastinal lymph node resection;
•2. The postoperative pathological diagnosis was primary non-small cell lung cancer stage I, stage II or carcinoma in situ;
•3. Meet the diagnosis of postoperative cough and cough occurs within one month after surgery;
•4. It conforms to the syndrome differentiation criteria of wind evil invading the lung and lung qi losing circulation;
•5. Aged 18-65 years old male or female;
•6. Day cough symptom score >=2 points and/or night cough symptom score >=2 points;
•7. Voluntary participation in the clinical trial, informed consent and signature of informed consent.

•1. Cough not caused by early postoperative non-small cell lung cancer;
•2. Those who meet the diagnostic criteria for non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, or targeted therapy;
•3. Those who have a history of allergies to the composition of Suhuang Zhike Capsule;
•4. Those who are participating in other clinical trials within 4 weeks before enrollment
•5. Cough caused by bronchitis;
•6. Patients who have had a cough before thoracoscopic pneumonectomy.

发起方